These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 27927852

  • 1. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
    Myer L, Dunning L, Lesosky M, Hsiao NY, Phillips T, Petro G, Zerbe A, McIntyre JA, Abrams EJ.
    Clin Infect Dis; 2017 Feb 15; 64(4):422-427. PubMed ID: 27927852
    [Abstract] [Full Text] [Related]

  • 2. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L, Phillips TK, McIntyre JA, Hsiao NY, Petro G, Zerbe A, Ramjith J, Bekker LG, Abrams EJ.
    HIV Med; 2017 Feb 15; 18(2):80-88. PubMed ID: 27353189
    [Abstract] [Full Text] [Related]

  • 3. Differentiated models of care for postpartum women on antiretroviral therapy in Cape Town, South Africa: a cohort study.
    Myer L, Iyun V, Zerbe A, Phillips TK, Brittain K, Mukonda E, Allerton J, Kalombo CD, Nofemela A, Abrams EJ.
    J Int AIDS Soc; 2017 Jul 21; 20(Suppl 4):21636. PubMed ID: 28770593
    [Abstract] [Full Text] [Related]

  • 4. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M, Glass T, Mukonda E, Hsiao NY, Abrams EJ, Myer L.
    J Int AIDS Soc; 2017 Nov 21; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [Abstract] [Full Text] [Related]

  • 5. Brief Report: Viral Load Monitoring in Pregnancy to Predict Peripartum Viremia in South Africa.
    Odayar J, Kabanda S, Malaba TR, Lesosky M, Myer L.
    J Acquir Immune Defic Syndr; 2021 Sep 01; 88(1):6-9. PubMed ID: 34050102
    [Abstract] [Full Text] [Related]

  • 6. Antiretroviral Adherence, Elevated Viral Load, and Drug Resistance Mutations in Human Immunodeficiency Virus-infected Women Initiating Treatment in Pregnancy: A Nested Case-control Study.
    Myer L, Redd AD, Mukonda E, Lynch BA, Phillips TK, Eisenberg A, Hsiao NY, Capoferri A, Zerbe A, Clarke W, Lesosky M, Breaud A, McIntyre J, Bruno D, Martens C, Abrams EJ, Reynolds SJ.
    Clin Infect Dis; 2020 Jan 16; 70(3):501-508. PubMed ID: 30877752
    [Abstract] [Full Text] [Related]

  • 7. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP, Wiener J, King CC, Heffron R, Mugo NR, Nanda K, Pyra M, Donnell D, Celum C, Lingappa JR, Baeten JM, Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams.
    J Acquir Immune Defic Syndr; 2017 Jan 01; 74(1):38-43. PubMed ID: 27787340
    [Abstract] [Full Text] [Related]

  • 8. HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
    le Roux SM, Donald KA, Kroon M, Phillips TK, Lesosky M, Esterhuyse L, Zerbe A, Brittain K, Abrams EJ, Myer L.
    Pediatr Infect Dis J; 2019 Jan 01; 38(1):70-75. PubMed ID: 30234792
    [Abstract] [Full Text] [Related]

  • 9. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.
    Phillips T, Thebus E, Bekker LG, Mcintyre J, Abrams EJ, Myer L.
    J Int AIDS Soc; 2014 Jan 01; 17(1):19242. PubMed ID: 25301494
    [Abstract] [Full Text] [Related]

  • 10. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.
    BJOG; 2013 Nov 01; 120(12):1534-47. PubMed ID: 23924192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    Onoya D, Sineke T, Brennan AT, Long L, Fox MP.
    AIDS; 2017 Jul 17; 31(11):1593-1602. PubMed ID: 28463877
    [Abstract] [Full Text] [Related]

  • 13. Linkage to care, mobility and retention of HIV-positive postpartum women in antiretroviral therapy services in South Africa.
    Phillips TK, Clouse K, Zerbe A, Orrell C, Abrams EJ, Myer L.
    J Int AIDS Soc; 2018 Jul 17; 21 Suppl 4(Suppl Suppl 4):e25114. PubMed ID: 30027583
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
    Gill MM, Hoffman HJ, Bobrow EA, Mugwaneza P, Ndatimana D, Ndayisaba GF, Baribwira C, Guay L, Asiimwe A.
    PLoS One; 2016 Jul 17; 11(12):e0168671. PubMed ID: 28006001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
    Ngarina M, Kilewo C, Karlsson K, Aboud S, Karlsson A, Marrone G, Leyna G, Ekström AM, Biberfeld G.
    BMC Infect Dis; 2015 Apr 08; 15():175. PubMed ID: 25886277
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Viraemia before, during and after pregnancy in HIV-infected women on antiretroviral therapy in rural KwaZulu-Natal, South Africa, 2010-2015.
    Chetty T, Newell ML, Thorne C, Coutsoudis A.
    Trop Med Int Health; 2018 Jan 08; 23(1):79-91. PubMed ID: 29121445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.